Alain Mina1, Steven Pavletic2, Peter D Aplan2,3

  • 1Myeloid Malignancies Program, Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. alain.mina@nih.gov.

Leukemia
|February 24, 2024
PubMed
概括

开发有效的治疗神经骨髓质瘤 (MDS) 需要更好的临床前模型. 本综述探讨了当前和新兴的模型,以加快新型MDS疗法的发展.